Although abnormalities in endothelial function are described in various insulm-resistant conditions, including obesity, diabetes, and hypertension in both huraans and animal models, the imderlying mechanisms are poorly understood. Experimental evidence suggests that (6R)-5,6,7,8-tetrahydrobiopterin (BH4), the natural and essential cofactor of NO synthases (NOS), plays a crucial role not only in increasing the rate of NO generation by NOS bat also in Controlling the formation of Superoxide anion (O2 ) in endothelial cells. Under insulin-resistant conditions where BH4 levels are suboptimal, the production of O2' by NO synthase leads to endothelial dysfunction. Furthermore, oral supplementation of BH4 (10 mg/kg/day) for 8 weeks restores endothelial function and relieved oxidative tissue damage, at least in part, through activation of eNOS in the aorta of insulin-resistant rats. These results suggest that abnormal pteridine metabolism contributes to causing endothelial dysfunction and the enhancement of vascular oxidative stress in the insulin-resistant State.
Introduction
dimeric, active form of the enzyme (7), may play a key role in the control of endothelial NO and O2 producInsulm resistance states such as obesity, hypertention in vivo. In fact, it has been demonstrated that sion and t>'pe 2 diabetes have been reported to be assoblood vessels depleted of BH4 produce O2 due to ciated with defective insulin-mediated and endotheliuncoupled oxygen activation (8) . In contrast, BH4 has um-dependent vasodilatation (1) (2) (3) . Endothelial dambeen used to reverse vascular dysfunction induced by age is of considerable clinical importance because the diabetes (9) and hypercholesterolemia (10) , suggcstmg endothelium is considered to play a central role in the that BH4 levels are compromised in these conditions. pathogenesis of atherosclerosis, and endothelial dysIn this review, mechanisms by which abnormal ptcrifunction has been implicated in preceding and likely dine metabolism affects vascular function and ulticontributing to the development of cardiovascular dismately contributes to vascular disease will be disease in these states (4, 5) . On the other hand, resistance cussed. to insulin's ability to augment blood flow responses to endothelium-dependent vasodilators was also demonMaterials and Methods strated in the insulin-resistant State. Insulin-resistant humans show delay in the delivery of insulin to the Insulin Resistance and Cardiovascular Diseases interstitial space (6) . Thus, impairment of insulin It is well known that the insulin-resistant State assoaction on the endothelial nitric oxide (NO) system ciated with compensatory hyperinsulinemia is tightly could account, at least in part, for derangement of NO linked to cardiovascular risk factors including essential production/action in the insulin-resistant State.
hypertension, obesity, type 2 diabetes, and dyslipiEvidence suggests that (6R)-5,6,7,8-tetrahydrodemia (11, 12) . We have recently shown that insulin biopterin (BH4), which is an important allosteric effecresistance promotes the development of obstructive tor of NO synthase (NOS) through stabilization of the coronary artery disease in non-diabetic subjects (13) Laakso et al., using the euglycemic insulin clamp techmque, first demonstrated the presence of insulin resistance m patients with asymptomatic atherosclerosis (stenotic lesion) in the femoral or carotid arteries (14) . We have confirmed the dose relation between insulin resistance and atherothrombotic cerebral infarction with angiographically proven carotid artery stenosis (15) . Recent clinical evidence has shown a possible link between diminished coronary vasodilator response to acetylcholine and hyperinsulinemia in patients with vasospastic angina (4, 5) . On the other hand, the response of coronary blood flow to N'^-monomethyl-L-arginine (L-NMMA), a competitive Inhibitor of NOS, were reduced in patients with \ asospastic angina and antioxidant treatment restored endothelial function in these patients (1, 2) . To mvestigate the underlying mechanisms for the relation between the insulin-resistant State and endothelial dysfunction, we examined the endothelial function and production of NO and Superoxide anion radical (O2") with the use of isolated thoracic aortas obtained from rats. We used a fructose-induced insulin-resistant model (fructose-fed rats), originally descnbed by Zavaroni et al. (16) llie maximal relaxation to both acet>'lcholine (receptor-mediated agonist) and A23187 (a receptor-independent endotheliumdependent vasodilator) was significantly reduced, and the ED50 values were increased in the aortas from fructose-fcd rats compared with those in the aortas from normal diet-fed rats. Endothelium-dependent vasodilation was restored by a scavenger of O2' in fructose-fed rats. In addition, L-NMMA not only inhibited the gcncration of NO, but also suppressed the increased O2 production in fructose-fed rats. On the other hand, vasodilator responses to sodium nitroprusside were comparable between the groups. Thus, in the msulin-resistant State, the reduced endotheliumdependent vasodilation is explained by mechanisms of a reduced NO production due to decreased NOS activity similar to accelerated degradation of NO by O2" within the vascular wall.
Pteridine Metabolism and Nitric Oxide Synthase in the Insulin-Resistant
State An increasing body of evidence suggests fhat vascular oxidative stress is involved in the pathogenesis of many cardiovascular diseases, including hypercholesterolemia, diabetes, hypertension, and heart failure (17, 18) . Among many enzymatic systems that are capable of producing reactive oxygen species (ROS), xanthine oxidase, NAD(P)H oxidase, and uncoupled eNOS have been extensively studied in vascular cells. Of note, eNOS constitutively produces both NO and 02', suggesting fhat the effective release of NO from the vascular endothelium depends on the relative concentrations of these two species. It has been demonstrated that blood vcsscls dcpleted of BH4 produce O2 due to uncoupled oxygen activation (19) .
The biosynthesis of intracellular BH4 is govemed by two enzymes: guanosine triphosphate cyclohydrolase I (GTP-CHl), which regulates its rate of formation, and dihydropteridine reductase (DHPR), which regulates its rate of regeneration. Utilization of BH4 in NO synthesis generates quinonoid dihydrobiopterin (qBH2) rather than BH2 (20, 21) . Altematively, qBH2 may rearrange non-enzymatically to BH2, which is no longer a substrate for DHPR (22) . To maintain BH4, increases in both enzyme activities are crucial. Impaired synthesis of BH4 due to decreased DHPR activity has been described in brain tissue of diabetic rats (23) . Interestingly, in adrenal glands, insulin stimulates BH4 synthesis by activation of GTP-CHl, the rate limiting enzyme in de novo synthesis of BH4, and BH4 synthesis is suggested to be decreased in the insulin-deficient State (24) . Tlius, it can be suggested that states of insulin resistance might also be associated with a defect in insulin's action to modulate pteridine metabolism.
Since eNOS inRNA expression was not changed in fructose-fed rats (24) , the impaired eNOS activity may be due to a decreased availability of the cofactor for endothelial synthesis of NO (25) . To evaluate the possible role of BH4 for the modulation of eNOSdependentNO/02 balance, we measured both BH4 and BH2 Contents in aortic tissue with or without endothelium. We found that endothelial BH4 content and G fP-CH1 activity were significantly decreased, whereas the levels of 7,8-BH2 were markedly increased in fiiictosefed rats (25) . In addition, with regard to the decreased DHPR activity, the marked decrement of BH4 relative to 7,8-BH2 (BH4/7,8-BH2 ratio) was observed in fructose-fed rats (25) . Since BH4 is rapidly oxidized to 7,8-BH2, a lack of sufificient DHPR activity would lead to accumulation of 7,8-BH2, which has been shown to inhibit the stimulatory effects of BH4 on NO synthase. In addition, high concentrations of 7,8-BH2 inhibit GTP-CHl and hence de novo synthesis of BH4 (26) . Therefore, these results suggest that insulin resistance induces vascular dysfunction through alterations in the BH4/7,8-BH2 ratio.
Effects of Oral Supplementation of Tetrahydrobiopterin on Endothelial Function and Vascular Oxidative Stress
To further confirm this hypothesis, we investigated the effects of dietary treatment with BH4 on endothelium-dependent arterial relaxation and vascular oxidative stress in the aortas of insulin-resistant rats (27 Oral supplementation of BH4 (10 mg/kg/day) for 8 vveeks significaiitly increased the BH4 content and BH4/7,8-BH2 ratio in aortic tissues of fructose-fed rats. Impairment of endothelium-dependent artenal relaxation Hl the aortic strips of the fructose-fed rats was reversed by BH4 treatment. The BII4 treatment was associated with a 2-fold mcrease in eNOS activity as well as a 70% reduction in endothelial O2 production compared with those in fructose-fed rats. Moreover, BH4 treatment of the fructose-fed rats markedly reduced the lipid peroxide content which were incrcased in fructose-fed rats. Furthermore, the increased binding activity of two redox-sensitive transcription factors, nuclear factor-kB and activating protein-1, in fructose-fed rats was also prevented by the treatment with BH4. Based on the fmding that activation of these transcnption factors is related to the alteration of the expression of various atherogenic genes (28), these results suggest that sufficient supplementation with BH4 might help to prevent or delay the occurrence of cardiovascular diseases in the insulin-resistant states.
Discussion
In conclusion, insulin resistance may be a pathogenic factor for endothelial dysfunction through impaired eNOS activity and increased oxidative breakdown of NO due to enlianced formation of O2 (N0/02' imbalance), which are caused by the relative deficiency of BH4 m vascular endothelial cells (Figuie). In addition, BH4 augmentation is essential for the restoration of endothelial function and the reduction of vascular oxidative stress in the insulin-resistant states.
